Displaying 1 - 10 of 145

Financial Press

Recipharm announces signature of letter of intent for aseptic fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate (mRNA-1273)

2020.11.24 Read more

Financial Press

Recipharm and Medspray establish joint venture to exploit novel softmist technology for pharmaceutical applications

2020.11.17 Read more

Financial Press

Invitation to the presentation of Recipharm’s interim report for the third quarter 2020

2020.11.02 Read more

Financial Press

Recipharm signs agreement with Arcturus Therapeutics to support the manufacture of LUNAR[®]-COV19 (ARCT-021) vaccine candidate

2020.10.06 Read more

Financial Press

Recipharm divests Portuguese distribution business and ophthalmology company for approximately EUR 31 million

2020.09.30 Read more

Financial Press

Change in the total number of shares and votes in Recipharm AB (publ)

2020.07.31 Read more

Financial Press

Invitation to the presentation of Recipharm’s interim report for the second quarter 2020

2020.07.22 Read more

Financial Press

Recipharm doubles EBIT and expects second quarter results to be stronger than analyst consensus

2020.07.13 Read more

Financial Press

Change in the total number of shares and votes in Recipharm AB (publ)

2020.06.30 Read more

Financial Press

Recipharm announces final result of the oversubscribed rights issue

2020.06.25 Read more